Master protocols are a cornerstone of the “critical path” for COVID-19 therapeutics proposed by a recent Duke-Margolis Center paper. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
